MedTrace Logo

Cameroon HepB Birth Dose Feasibility Pilot

NCT04893616 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2022-07-25

No results posted yet for this study

Summary

This feasibility assessment is to provide quantitative findings of an intervention integrating immunizations into maternity and newborn care across 15 health facilities in Cameroon.

Conditions

Interventions

OTHER

Integration of vaccination services into delivery services

The purpose of the work is to integrate readily available birth dose vaccinations (Oral Polio and the Tuberculosis vaccine) currently given in a separate clinic into the maternity delivery services through improved training, checklist, and job aides.

Sponsors & Collaborators

  • Cameroon Expanded Program on Immunization

    collaborator UNKNOWN

  • Bill and Melinda Gates Foundation

    collaborator OTHER

  • Clinton Health Access Initiative Inc.

    lead OTHER

Principal Investigators

  • Ankouane Andoulo Firmin · Faculty of Medicine and Bio-Medical Sciences, University of Yaoundé

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-06-10
Primary Completion
2021-12-11
Completion
2021-12-31

Countries

  • Cameroon

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04893616 on ClinicalTrials.gov